To conclude the results of meta-analysis II, cancer patients with high dysadherin staining face a 1.5-times the risk of death compared to cancer patients with low tumoral dysadherin level, although the heterogeneity between studies is large (Cochran Q = 4.6365, p-value = 0.0313, degrees of freedom = 1 and I2 = 78.43%). Here, FXYD5 is linked to cancer.